Kodiak Sciences Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $0TTM through 30 Jun 2026
Net Income -$242MTTM through 30 Jun 2026
Free Cash Flow -$159.9MTTM through 30 Jun 2026
Margins
| Current |
|---|
Returns
-205.8%ROE
-75.4%ROA
Balance Sheet Health
Debt / Equity0.00x
Current Ratio4.72x
Net Debt-$169.5Mnet cash position
Cash & Equivalents$125.9M
Quality Metrics
Altman Z-Score-5.46
Piotroski F-Score1 / 9
Earnings-Beat Rate75.0%
Multi-Year Trend
Diluted EPS-$4.19TTMFY2025: $-4.32
Dividend
No dividend
Capital Allocation
R&D Spend$200.6M
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.